# Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia

> **NCT03862040** · PHASE1 · TERMINATED · sponsor: **Shionogi** · enrollment: 7 (actual)

## Conditions studied

- Bacterial Pneumonia

## Interventions

- **DRUG:** Cefiderocol
- **DRUG:** Standard of Care Antibiotic

## Key facts

- **NCT ID:** NCT03862040
- **Lead sponsor:** Shionogi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2019-02-20
- **Primary completion:** 2019-10-08
- **Final completion:** 2019-10-15
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** Slow enrollment
- **Last updated:** 2020-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03862040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03862040, "Cefiderocol Concentrations in the Lungs of Hospitalized Patients With Bacterial Pneumonia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03862040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*